Education
About Us
Working with TipRanks
Follow Us
Michael Aaron Kelly Insider Profile
4 Followers
Michael Aaron Kelly, Director at Hookipa Pharma, holds 72.47K shares in Amicus (Ticker: FOLD), holds 49.01K shares in NeoGenomics (Ticker: NEO), holds 48.65K shares in DMC Global (Ticker: BOOM).
Michael Aaron Kelly has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Aaron Kelly holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Aaron Kelly
Michael Aaron Kelly's Trading History
Hookipa Pharma
Oct 23, 2020
Director
Uninformative Buy
―
$5.19K
DMC Global
May 15, 2025
Director
Uninformative Buy
―
$323.54K
NeoGenomics
Jun 03, 2025
Director
Uninformative Buy
89.21K
$269.06K
Aprea Therapeutics
Jul 01, 2021
Director
Uninformative Buy
―
$7.56K
Amicus
Jun 06, 2025
Director
Uninformative Buy
―
$502.20K
Prime Medicine, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Michael Aaron Kelly's performance on stock
You May Also Like
Michael Aaron Kelly insider profile FAQ
What is the percentage of profitable transactions made by Michael Aaron Kelly?
The percentage of profitable transactions made by Michael Aaron Kelly is ―.
What is the average return per transaction made by Michael Aaron Kelly?
The average return per transaction made by Michael Aaron Kelly is ―.
What stocks does Michael Aaron Kelly hold?
Michael Aaron Kelly holds: HOOK, BOOM, NEO, APRE, FOLD, PRME stocks.
What was Michael Aaron Kelly’s latest transaction?
Michael Aaron Kelly latest transaction was an Uninformative Buy of ―.
What was Michael Aaron Kelly's most profitable transaction?
Michael Aaron Kelly’s most profitable transaction was an Informative Buy of NEO stock on May 28, 2025. The return on the trade was -30.40%.
What is Michael Aaron Kelly's role in Hookipa Pharma?
Michael Aaron Kelly's role in Hookipa Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.